Mike Gavrielides

London, ENG NW11AT, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancer.

Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancer.

Journal: Cell reports. Medicine
Published: June 06, 2022

Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer.

Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer.

Journal: Cancer cell
Published: April 12, 2022

Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancer.

Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancer.

Journal: Cancer cell
Published: March 30, 2022

Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer.

Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer.

Journal: Cancer cell
Published: December 30, 2021

Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer.

Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer.

Journal: Lancet (London, England)
Published: December 29, 2021

Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: The CAPTURE study.

Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: The CAPTURE study.

Journal: Nature cancer
Published: December 24, 2021

Functional antibody and T-cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study.

Functional antibody and T-cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study.

Journal: Research square
Published: September 28, 2021

Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study.

Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study.

Journal: Nature cancer
Published: August 23, 2021

Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study.

Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study.

Journal: Nature cancer
Published: August 18, 2021

The mutational burden of acral melanoma revealed by whole-genome sequencing and comparative analysis.

The mutational burden of acral melanoma revealed by whole-genome sequencing and comparative analysis.

Journal: Pigment cell & melanoma research
Published: March 27, 2014

Onco-STS: a web-based laboratory information management system for sample and analysis tracking in oncogenomic experiments.

Onco-STS: a web-based laboratory information management system for sample and analysis tracking in oncogenomic experiments.

Journal: Source code for biology and medicine
Published: October 23, 2013
Showing 1-11 of 11

Last Updated: 09/26/2026